Mercante Jeffrey, Edwards Adrianne N, Dubey Ashok K, Babitzke Paul, Romeo Tony
Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
J Mol Biol. 2009 Sep 18;392(2):511-28. doi: 10.1016/j.jmb.2009.07.034. Epub 2009 Jul 17.
The global regulatory protein CsrA binds to the 5'-untranslated leader of target transcripts and alters their translation and/or stability. CsrA is a symmetrical homodimer containing two identical RNA-binding surfaces. Gel shift assays with model RNA substrates now show that CsrA can bind simultaneously at two target sites within a transcript (bridging or dual-site binding). An intersite distance of approximately 18 nucleotides (nt) was optimal, although bridging occurred with an intersite distance of 10 to >or=63 nt. The close 10-nt spacing reduced the stability of dual-site binding, as competition for one site by a second CsrA dimer readily occurred. Both RNA-binding surfaces of a single CsrA protein were essential for efficient in vitro repression of a glgC'-'lacZ translational fusion that contains four CsrA target sites within the untranslated leader. Heterodimeric CsrA (HD-CsrA) containing a single R44A replacement, which was defective for binding at its mutant surface but bound RNA normally at its wild-type (WT) surface, was approximately 14-fold less effective at repression than homodimeric WT-CsrA. Furthermore, deletion of a CsrA target site of glgC that lies upstream from the Shine-Dalgarno sequence did not affect regulation by HD-CsrA but decreased regulation by WT-CsrA, confirming a regulatory role of dual-site binding. Finally, we propose a mechanism whereby a globular ribonucleoprotein complex is formed between CsrA and its noncoding RNA antagonist, CsrB. Because many target sites of CsrB are located closer together than is optimal for bridging, binding to nonadjacent sites should be energetically favored, causing multiple CsrA dimers to tether CsrB into the observed globular form rather than an extended CsrA-CsrB complex.
全局调控蛋白CsrA与靶转录本的5'非翻译前导区结合,并改变其翻译和/或稳定性。CsrA是一种对称的同二聚体,包含两个相同的RNA结合表面。现在,使用模型RNA底物进行的凝胶迁移实验表明,CsrA可以在转录本内的两个靶位点同时结合(桥接或双位点结合)。尽管在10至≥63个核苷酸(nt)的位点间距下也会发生桥接,但约18个核苷酸(nt)的位点间距是最佳的。紧密的10个nt间距降低了双位点结合的稳定性,因为第二个CsrA二聚体很容易与一个位点竞争。单个CsrA蛋白的两个RNA结合表面对于有效体外抑制glgC'-'lacZ翻译融合至关重要,该融合在非翻译前导区内包含四个CsrA靶位点。含有单个R44A替代的异源二聚体CsrA(HD-CsrA),在其突变表面结合存在缺陷,但在其野生型(WT)表面正常结合RNA,其抑制作用比同二聚体WT-CsrA低约14倍。此外,删除位于Shine-Dalgarno序列上游的glgC的一个CsrA靶位点不影响HD-CsrA的调控,但会降低WT-CsrA的调控,证实了双位点结合的调控作用。最后,我们提出了一种机制,即CsrA与其非编码RNA拮抗剂CsrB之间形成球状核糖核蛋白复合物。由于CsrB的许多靶位点比桥接的最佳间距靠得更近,因此与非相邻位点的结合在能量上应该更有利,导致多个CsrA二聚体将CsrB束缚成观察到的球状形式,而不是延伸的CsrA-CsrB复合物。